Last reviewed · How we verify
NCT03505957
A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population
NA trial testing SafeBreak Vascular in IV Dislodgement in 40 participants. Completed in 23 September 2018.
23 September 2018
Quick facts
| Lead sponsor | Lineus Medical |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 7 May 2018 |
| Primary completion | 23 September 2018 |
| Estimated completion | 23 September 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SafeBreak Vascular
Conditions studied
- IV Dislodgement — all drugs for IV Dislodgement →
Sponsor
Lineus Medical
Who can join
55 and older, any sex, with IV Dislodgement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of unintended disruption and dislodgment of IVs. SafeBreak Vascular may be used for any hospitalized patient with gravity tubing or IV pumps, for intermittent infusion or continuous infusion.The primary objective of this study is to determine if the delivery of IV medications and/or fluids with SafeBreak Vascular functions with the same reliability as current standard IV tubing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03505957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SafeBreak Vascular
Trials testing the same drug.
- NCT04469218 — A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications · NA · completed
Other Lineus Medical trials
Trials by the same sponsor.
- NCT04469218 — A Clinical Trial Using a New Medical Device to Evaluate Its Impact on IV Care and Clinical Complications · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03505957 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lineus Medical
- Last refreshed: 5 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03505957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing